Identification and Functional Characterization of the Caenorhabditis elegans Riboflavin Transporters rft-1 and rft-2
暂无分享,去创建一个
[1] W. G. Stevenson. Riboflavin Deficiency. , 2022, Canadian journal of comparative medicine and veterinary science.
[2] H. Said,et al. Mechanism and regulation of vitamin B2 (riboflavin) uptake by mouse and human pancreatic β-cells/islets: physiological and molecular aspects. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[3] H. Said,et al. Effect of clinical mutations on functionality of the human riboflavin transporter-2 (hRFT-2). , 2012, Molecular genetics and metabolism.
[4] C. Spagnoli,et al. Brown‐Vialetto‐Van Laere syndrome and Fazio‐Londe disease – treatable motor neuron diseases of childhood , 2012, Developmental medicine and child neurology.
[5] J. Marchant,et al. Differential expression of human riboflavin transporters -1, -2, and -3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. , 2011, Biochimica et biophysica acta.
[6] Katsuhisa Inoue,et al. Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption. , 2010, The Journal of nutrition.
[7] K. Balamurugan,et al. Knockout of the folate transporter folt-1 causes germline and somatic defects in C. elegans , 2010, BMC Developmental Biology.
[8] Y. Crow,et al. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. , 2010, American journal of human genetics.
[9] Yutong He,et al. Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China. , 2009, Asian Pacific journal of cancer prevention : APJCP.
[10] S. Sathasivam. Brown-Vialetto-Van Laere syndrome , 2008, Orphanet journal of rare diseases.
[11] M. Moussaif,et al. the nematode, Caenorhabditis elegans , 2022 .
[12] J. McGhee. The C. elegans intestine. , 2007, WormBook : the online review of C. elegans biology.
[13] Cori Bargmann. Chemosensation in C. elegans. , 2006, WormBook : the online review of C. elegans biology.
[14] T. Blumenthal. Trans-splicing and operons. , 2005, WormBook : the online review of C. elegans biology.
[15] V. Ganapathy,et al. Relevance of NAC-2, an Na+-coupled citrate transporter, to life span, body size and fat content in Caenorhabditis elegans. , 2004, The Biochemical journal.
[16] B. Lemire,et al. Mitochondrial complex I mutations in Caenorhabditis elegans produce cytochrome c oxidase deficiency, oxidative stress and vitamin-responsive lactic acidosis. , 2003, Human molecular genetics.
[17] V. Ganapathy,et al. Structural and Functional Characteristics of Two Sodium-coupled Dicarboxylate Transporters (ceNaDC1 and ceNaDC2) fromCaenorhabditis elegans and Their Relevance to Life Span* , 2003, The Journal of Biological Chemistry.
[18] Oliver Hobert,et al. PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. , 2002, BioTechniques.
[19] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[20] E. Park,et al. Microbial production of riboflavin using riboflavin overproducers,Ashbya gossypii, Bacillus subtilis, andCandida famate: An overview , 2001 .
[21] A. Fire,et al. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. , 2001, Gene.
[22] V. Ganapathy,et al. Identity of the F52F12.1 gene product in Caenorhabditis elegans as an organic cation transporter. , 1999, Biochimica et biophysica acta.
[23] Kamble Sm,et al. MOLYBDENUM, XANTHINE OXIDASE AND RIBOFLAVIN LEVELS IN TAMOXIFEN TREATED POSTMENOPAUSAL WOMEN WITH BREAST CANCER , 1998 .
[24] L. Hjelmeland,et al. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.
[25] M Macaluso,et al. A case control study of nutritional factors and cervical dysplasia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[26] K. Krishnaswamy,et al. Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[27] N. Munakata. [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[28] C. Kenyon,et al. The nematode Caenorhabditis elegans. , 1988, Science.
[29] J. Vanfleteren,et al. Intermediary metabolism. , 2009, WormBook : the online review of C. elegans biology.
[30] M. Labouesse. [Caenorhabditis elegans]. , 2003, Medecine sciences : M/S.
[31] S. Kamble,et al. Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer. , 1998, Indian journal of medical sciences.
[32] W. Wood. The Nematode Caenorhabditis elegans , 1988 .
[33] L. Machlin. Handbook of vitamins: nutritional, biochemical, and clinical aspects. , 1984 .